News tagged with clozapine
Clozapine
Clozapine (sold as Clozaril, Azaleptin, Leponex, Fazaclo, Froidir; Denzapine, Zaponex in the UK; Klozapol in Poland, Clopine in Australia and New Zealand) is an antipsychotic medication used in the treatment of schizophrenia, and is also used off-label in the treatment of bipolar disorder. Wyatt. R and Chew. R (2005) tells us there are three pharmaceutical companies that market this drug at present: Novartis Pharmaceuticals (manufacturer), Mylan Laboratories and Ivax Pharmaceuticals (market generic clozapine). The first of the atypical antipsychotics to be developed, it was first introduced in Europe in 1971, but was voluntarily withdrawn by the manufacturer in 1975 after it was shown to cause agranulocytosis, a condition involving a dangerous decrease in the number of white blood cells, that led to death in some patients. In 1989, after studies demonstrated that it was more effective than any other antipsychotic for treating schizophrenia[citation needed], the U.S. Food and Drug Administration (FDA) approved clozapine's use but only for treatment-resistant schizophrenia. The FDA requires blood testing for patients taking clozapine. The FDA also requires clozapine to carry five black box warnings for agranulocytosis, seizures, myocarditis, for "other adverse cardiovascular and respiratory effects", and for "increased mortality in elderly patients with dementia-related psychosis." In 2002 the FDA approved clozapine for reducing the risk of suicidal behavior for patients with schizophrenia.
Clozapine is usually used as a last resort in patients that have not responded to other anti-psychotic treatments due to its danger of causing agranulocytosis as well as the costs of having to have blood tests continually during treatment. It is, however, one of the very effective anti-psychotic treatment choices. Patients are monitored weekly for the first six months. If there are no low counts the patient can be monitored every two weeks for an additional six months. Afterwards, the patient may qualify for every 4 week monitoring. Clozapine has numerous severe side effects including agranulocytosis, bowel infarction, seizures, myocarditis, and diabetes. Additionally, it also often causes less serious side effects such as sialorrhea and weight gain.
For more information about Clozapine, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
EEG predicts response to medication for schizophrenia
A commonplace electroencephalography (EEG) test may hold the key to predicting whether a person will respond to certain prescribed drugs, particularly those related to psychiatric conditions.
Medicine & Health / Neuroscience
Aug 04, 2010 |
4.5 / 5 (4) |
1
Schizophrenia drugs raise the volume of a key signaling system in the brain
All the major groups of medications for schizophrenia turn up the volume of a brain signal known to be muted in individuals with this psychiatric disorder -- a signal that also can be influenced by diet. "This ...
Medicine & Health / Neuroscience
May 12, 2010 |
5 / 5 (3) |
3
|
Study: Clozapine may have saved schizophrenics
(AP) -- Thousands of people with schizophrenia worldwide could have been saved if doctors had prescribed them the anti-psychotic drug clozapine, a new study says.
Jul 13, 2009 |
5 / 5 (3) |
4
Study shows how microscopic changes to brain cause schizophrenic behavior in mice
The findings are being published in an Early Edition of the journal Proceedings of the National Academy of Sciences this week.
Feb 19, 2009 |
5 / 5 (2) |
0
Search results for clozapine
AAN releases updated guideline for treating essential tremor
The American Academy of Neurology is releasing an updated guideline on how to best treat essential tremor, which is the most common type of tremor disorder and is often confused with other movement disorders such as Parkinson's ...
Medicine & Health / Neuroscience
Oct 19, 2011 |
4 / 5 (1) |
0
Researchers develop mouse with 'off switch' in key brain cell population
NIH-funded scientists have developed a strain of mice with a built-in off switch that can selectively shut down the animals' serotonin-producing cells, which make up a brain network controlling breathing, temperature regulation, ...
Jul 28, 2011 |
5 / 5 (2) |
1
|
Why symptoms of schizophrenia emerge in young adulthood
In reports of two new studies, researchers led by Johns Hopkins say they have identified the mechanisms rooted in two anatomical brain abnormalities that may explain the onset of schizophrenia and the reason symptoms don't ...
Medicine & Health / Neuroscience
Feb 26, 2010 |
4.9 / 5 (9) |
1
|
Stopping schizophrenia before it starts?
The onset of schizophrenia is not easy to predict. Although it is associated with as many as 14 genes in the human genome, the prior presence of schizophrenia in the family is not enough to determine whether ...
Medicine & Health / Psychology & Psychiatry
Jan 28, 2010 |
not rated yet |
0
Scientists create entirely new way to study brain function
(PhysOrg.com) -- Scientists at Duke University and the University of North Carolina have devised a chemical technique that promises to allow neuroscientists to discover the function of any population of neurons in an animal ...
Medicine & Health / Neuroscience
Jul 15, 2009 |
4.7 / 5 (3) |
1
Researchers reveal how the brain processes important information
Researchers at UT Southwestern Medical Center have shed light on how the neurotransmitter dopamine helps brain cells process important information.
Medicine & Health / Neuroscience
Apr 02, 2009 |
1 / 5 (1) |
0
Researchers discover new link to schizophrenia
Neuroscientists at Johns Hopkins have discovered that mice lacking an enzyme that contributes to Alzheimer disease exhibit a number of schizophrenia-like behaviors. The finding raises the possibility that this enzyme may ...
May 08, 2008 |
4.5 / 5 (2) |
0
Comparison of antipsychotic treatments in adolescents with schizophrenia
There is a wealth of scientific literature available on the treatment of adults diagnosed with schizophrenia. However, there is a paucity of data to guide the treatment of children and adolescents with schizophrenia.
Feb 28, 2008 |
5 / 5 (1) |
0
New treatment mechanisms for schizophrenia
The field of schizophrenia research has come alive with many exciting new potential approaches to treatment. From the introduction of chlorpromazine to the current day, all treatments approved by the U.S. Food and Drug Administration ...
Jan 08, 2008 |
4.6 / 5 (5) |
0
How schizophrenia develops: Major clues discovered
Schizophrenia may occur, in part, because of a problem in an intermittent on/off switch for a gene involved in making a key chemical messenger in the brain, scientists have found in a study of human brain tissue. The researchers ...
Oct 16, 2007 |
4.6 / 5 (22) |
0
List of search results for clozapine